天邦股份(002124.SZ):1月商品豬銷售收入3.77億元 同比降12.9%
格隆匯2月3日丨天邦股份(002124.SZ)披露2020年1月份商品豬銷售情況簡報,公司2020年1月份銷售商品豬11.69萬頭,銷售收入約3.77億元,銷售均價38.72元/公斤(剔除仔豬、種豬價格影響後為33.18元/公斤),環比變動分別為-35.82%、-45.40%、13.17%。商品豬銷售頭數、銷售收入、銷售均價同比變動分別為-66.50%、-12.90%、283.00%。
公司2020年1月份生豬銷售量和銷售收入減少主要是由於2019年受到非洲豬瘟疫情影響,公司育肥豬存欄量下降,出欄量和銷售收入相應減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.